X
DGX icon

Xponance’s Quest Diagnostics DGX Stock Holding History

Xponance’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Sell
20,436
-975
-5% -$191K 0.03% 422
2026
Q1 		$4.2M Buy
21,411
+1,837
+9% +$357K 0.03% 401
2025
Q4 		$3.4M Buy
19,574
+776
+4% +$141K 0.03% 424
2025
Q3 		$3.58M Sell
18,798
-2,517
-12% -$447K 0.03% 404
2025
Q2 		$3.83M Buy
21,315
+4,843
+29% +$841K 0.03% 397
2025
Q1 		$2.79M Sell
16,472
-929
-5% -$153K 0.03% 449
2024
Q4 		$2.63M Buy
17,401
+795
+5% +$124K 0.02% 457
2024
Q3 		$2.58M Buy
16,606
+216
+1% +$32.3K 0.02% 459
2024
Q2 		$2.24M Sell
16,390
-1,057
-6% -$145K 0.02% 473
2024
Q1 		$2.32M Buy
17,447
+2,490
+17% +$323K 0.02% 481
2023
Q4 		$2.06M Sell
14,957
-1,615
-10% -$212K 0.02% 467
2023
Q3 		$2.02M Buy
16,572
+2,025
+14% +$270K 0.03% 458
2023
Q2 		$2.04M Buy
14,547
+146
+1% +$20.1K 0.03% 462
2023
Q1 		$2.04M Sell
14,401
-8,562
-37% -$1.22M 0.03% 451
2022
Q4 		$3.59M Buy
22,963
+1,804
+9% +$259K 0.06% 295
2022
Q3 		$2.6M Sell
21,159
-3,027
-13% -$399K 0.05% 333
2022
Q2 		$3.22M Sell
24,186
-16,141
-40% -$2.2M 0.06% 260
2022
Q1 		$5.52M Sell
40,327
-562
-1% -$78.3K 0.09% 184
2021
Q4 		$7.07M Buy
40,889
+15,397
+60% +$2.34M 0.11% 164
2021
Q3 		$3.7M Sell
25,492
-1,623
-6% -$237K 0.07% 230
2021
Q2 		$3.58M Sell
27,115
-5,171
-16% -$677K 0.07% 239
2021
Q1 		$4.14M Sell
32,286
-22
-0.1% -$2.71K 0.09% 192
2020
Q4 		$3.85M Buy
32,308
+26,470
+453% +$3.23M 0.08% 197
2020
Q3 		$668K Buy
5,838
+15
+0.3% +$1.77K 0.02% 535
2020
Q2 		$664K Buy
+5,823
New +$618K 0.02% 491

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Xponance's DGX Position: Q2 2026 in Review

Xponance reduced its Quest Diagnostics (DGX) stake by 4.6% in Q2 2026, selling an estimated $191K and leaving 20,436 shares worth $4.33M. The position accounts for 0.03% of the portfolio, ranked #422.

Xponance first reported a position in DGX in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.07M in Q4 2021. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Xponance held 20,436 shares of Quest Diagnostics worth $4.33M as of Q2 2026.
  • Xponance sold 975 Quest Diagnostics shares in Q2 2026, an estimated $191K.
  • Quest Diagnostics made up 0.03% of Xponance's portfolio in Q2 2026, its #422 holding.
  • Xponance first reported a position in Quest Diagnostics in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Quest Diagnostics position peaked at $7.07M in Q4 2021.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.